Geovax Labs, INC. (GOVX) — 8-K Filings

All 8-K filings from Geovax Labs, INC.. Browse 29 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (29)

GeoVax Labs Enters Material Definitive Agreement — Dec 22, 2025 Risk: medium
On December 19, 2025, GeoVax Labs, Inc. entered into a material definitive agreement. The filing also includes Regulation FD disclosures and financial statement
8-K Filing — Nov 26, 2025
GeoVax Labs Files 8-K: Agreements, Equity Sales, and Financials — Sep 30, 2025 Risk: medium
On September 30, 2025, GeoVax Labs, Inc. filed an 8-K report detailing several key events. The company entered into a material definitive agreement, reported un
GeoVax Labs Faces Listing Rule Issues — Aug 1, 2025 Risk: high
GeoVax Labs, Inc. filed an 8-K on August 1, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and also filed fin
GeoVax Labs Files 8-K on Financials — Jul 29, 2025 Risk: low
On July 28, 2025, GeoVax Labs, Inc. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements and ex
GeoVax Labs Files 8-K with Material Agreement — Jul 2, 2025 Risk: medium
On July 1, 2025, GeoVax Labs, Inc. entered into a material definitive agreement. The company also provided a Regulation FD disclosure and filed financial statem
GeoVax Labs Files 8-K on Security Holder Vote Matters — Jun 5, 2025 Risk: low
GeoVax Labs, Inc. filed an 8-K on June 5, 2025, reporting on a submission of matters to a vote of security holders. The filing does not contain specific details
GeoVax Labs Terminates Material Agreement — Apr 14, 2025 Risk: medium
GeoVax Labs, Inc. filed an 8-K on April 14, 2025, to report the termination of a material definitive agreement. The filing date indicates the event occurred on
GeoVax Labs Files 8-K on Financials — Mar 28, 2025 Risk: low
GeoVax Labs, Inc. filed an 8-K on March 28, 2025, reporting on its Results of Operations and Financial Condition as of March 27, 2025. The filing includes finan
GeoVax Labs Files 8-K: Material Agreement, FD Disclosure — Mar 25, 2025 Risk: medium
On March 23, 2025, GeoVax Labs, Inc. entered into a Material Definitive Agreement. The company also provided a Regulation FD Disclosure and filed financial stat
GeoVax Labs Files 8-K on Shareholder Vote Matters — Jan 22, 2025 Risk: medium
On January 22, 2025, GeoVax Labs, Inc. filed an 8-K report detailing a submission of matters to a vote of its security holders. The filing does not specify the
GeoVax Labs Files 8-K: Corporate Details Updated — Dec 18, 2024 Risk: low
GeoVax Labs, Inc. filed an 8-K on December 18, 2024, reporting an event under 'Other Events'. The filing details the company's incorporation in Delaware, its IR
GeoVax Labs Faces Delisting Notice — Nov 18, 2024 Risk: high
GeoVax Labs, Inc. filed an 8-K on November 18, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company is
GeoVax Labs Files 8-K on Financials and Operations — Nov 13, 2024 Risk: medium
GeoVax Labs, Inc. filed an 8-K on November 13, 2024, reporting on its financial condition and other events. The filing includes information on results of operat
GeoVax Labs Files 8-K Report — Oct 16, 2024 Risk: medium
On October 16, 2024, GeoVax Labs, Inc. filed an 8-K report detailing an "Other Event." The filing does not provide specific details about the event itself, but
GeoVax Labs Files 8-K: Corporate Updates — Oct 15, 2024 Risk: low
GeoVax Labs, Inc. filed an 8-K on October 15, 2024, reporting other events and financial statements. The filing details the company's incorporation in Delaware,
GeoVax Labs Files 8-K Report — Oct 1, 2024 Risk: low
On October 1, 2024, GeoVax Labs, Inc. filed an 8-K report detailing an "Other Event." The filing does not specify the exact nature of this event but is a standa
GeoVax Labs Files Material Definitive Agreement 8-K — Sep 25, 2024 Risk: medium
On September 25, 2024, GeoVax Labs, Inc. filed an 8-K report detailing a material definitive agreement. The filing does not specify the other party involved in
GeoVax Labs Files 8-K: Corporate Updates — Sep 17, 2024 Risk: low
GeoVax Labs, Inc. filed an 8-K on September 17, 2024, reporting other events and financial statements. The filing details the company's corporate structure, inc
GeoVax Labs Files 8-K: Material Agreement & Equity Sales — Aug 30, 2024 Risk: medium
GeoVax Labs, Inc. entered into a material definitive agreement on August 28, 2024, related to unregistered sales of equity securities. The company also disclose
GeoVax Labs Files 8-K: Material Agreement & Equity Sales — Aug 21, 2024 Risk: medium
GeoVax Labs, Inc. announced on August 20, 2024, that it entered into a Material Definitive Agreement. The company also disclosed unregistered sales of equity se
GeoVax Labs Files 8-K on Financials — Aug 7, 2024 Risk: medium
On August 6, 2024, GeoVax Labs, Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements a
GeoVax Labs Files 8-K: Material Agreement & Equity Sale — Jul 12, 2024 Risk: medium
On July 11, 2024, GeoVax Labs, Inc. entered into a material definitive agreement related to the unregistered sale of equity securities. The company also made a
GeoVax Labs Faces Delisting Concerns — Jun 21, 2024 Risk: high
GeoVax Labs, Inc. filed an 8-K on June 21, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing indicates potential
GeoVax Labs Enters Material Definitive Agreement — Jun 18, 2024 Risk: medium
On June 12, 2024, GeoVax Labs, Inc. entered into a Material Definitive Agreement. The company, incorporated in Delaware with its principal office in Smyrna, GA,
GeoVax Labs Faces Delisting Concerns — May 24, 2024 Risk: high
GeoVax Labs, Inc. filed an 8-K on May 24, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is based in Smyrna,
GeoVax Labs Files 8-K on Corporate Matters — May 23, 2024 Risk: low
GeoVax Labs, Inc. filed an 8-K on May 23, 2024, reporting on amendments to its articles of incorporation or bylaws, submission of matters to a vote of security
GeoVax Labs Files 8-K: Equity Sales and Agreements — May 21, 2024 Risk: medium
On May 16, 2024, GeoVax Labs, Inc. entered into a material definitive agreement related to the sale of its common stock and warrants. The company also disclosed
GeoVax Labs Files 8-K on Financials — May 15, 2024 Risk: low
GeoVax Labs, Inc. filed an 8-K on May 15, 2024, reporting on its results of operations and financial condition as of May 14, 2024. The filing includes financial

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX